AG

Anusha Gudivaka

Active Director Director DIN 08729524
DIN 08729524 First appointment Mar 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Anusha Gudivaka

Data last updated:

Anusha Gudivaka is a Director at Gudivaka Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Gudivaka Pharmaceuticals Private Limited reported revenue of ₹1.09 Cr (FY 2022).

DIN 08729524
Primary Designation Director
Industry Chemicals
First Appointment 20 Mar 2020
Oldest Company Age 6 yrs
Largest company Gudivaka Pharmaceuticals Private Limited · ₹1.09 Cr (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Mar 20202020₹1.09 Cr (FY 2022)Active

Board colleagues of Anusha Gudivaka

Directorship timeline

Open interactive timeline →
Gudivaka Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anusha Gudivaka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anusha Gudivaka

Anusha Gudivaka currently holds 1 directorship: Gudivaka Pharmaceuticals Private Limited (Director, since 20 Mar 2020, revenue ₹1.09 Cr (FY 2022)).

Anusha Gudivaka was first appointed on 20 Mar 2020 as Director at Gudivaka Pharmaceuticals Private Limited.

The current boards of Anusha Gudivaka's companies include Ramanjaneyulu Gudivaka (Gudivaka Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available